NCT05904782

Brief Summary

To learn more about the experience and wellbeing of people who provide care for cancer patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
15mo left

Started Aug 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Aug 2025Nov 2027

First Submitted

Initial submission to the registry

June 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
2.2 years until next milestone

Study Start

First participant enrolled

August 29, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

2.2 years

First QC Date

June 6, 2023

Last Update Submit

March 2, 2026

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Quality of Life questionnaire (Qol)

    through completion of study; approximately 1 month

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

MD Anderson Cancer Center

You may qualify if:

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Males and female adults ≥18 years
  • Able to read and speak English
  • Caregiver of a patient diagnosed with stage IV solid malignancy, with whom they have been residing for \>6 months
  • Access to necessary resources for participating in a technology-based intervention (i.e., telephone, internet access)

You may not qualify if:

  • Current participation in consistent (self-defined) psychotherapy
  • Caregivers who are considered part of a vulnerable population (i.e. cognitively impaired (self-reported or patient-reported), pregnant, military personnel) will not be eligible.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Juliet Kroll

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Juliet Kroll

CONTACT

(346) 723-5858jlkroll@mdanderson.org

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2023

First Posted

June 15, 2023

Study Start

August 29, 2025

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations

US(1)